Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
6,273,385
-
Share change
-
-361,406
-
Total reported value
-
$11,371,497
-
Put/Call ratio
-
0%
-
Price per share
-
$1.81
-
Number of holders
-
30
-
Value change
-
+$17,317
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q1 2024
As of 31 Mar 2024,
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,273,385 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Tejara Capital Ltd, AdvisorShares Investments LLC, Cambridge Investment Research Advisors, Inc., Laird Norton Wetherby Trust Company, LLC, MGO ONE SEVEN LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF MONTREAL /CAN/, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.